Chinese Pharma Co. Raises $90M For Respiratory Therapies
China-based CF PharmTech said Thursday it has raised $90 million from a range of Chinese and international investors that the pharmaceutical company will put toward development of its respiratory drugs....To view the full article, register now.
Already a subscriber? Click here to view full article